Fu‐Cai Ren
Impact in
- Pharmacology top 5%
- Biological and pharmacological studies of plants
- Plant Science top 10%
- Phytochemistry and Biological Activities
- Polysaccharides and Plant Cell Walls
Papers in
-
- Natural product bioactivities and synthesis 17
- Bioactive natural compounds 10
- Bioactive Natural Diterpenoids Research 5
-
- Phytochemistry and Biological Activities 17
- Co-authors
- Ji‐Kai Liu (8 shared papers)Fei Wang (11 shared papers)Jiang‐Miao Hu (9 shared papers)Yong-Feng Lv (8 shared papers)Liu Yang (6 shared papers)Jun Zhou (5 shared papers)Jinyu Li (2 shared papers)Guozhu Wei (5 shared papers)
- Journals
- Molecules (7 papers)Natural Products and Bioprospecting (6 papers)Fitoterapia (6 papers)Phytochemistry (5 papers)Helvetica Chimica Acta (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Fu‐Cai Ren
48 papers receiving 632 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 192
- Pharmacology 92
- Plant Science 275
- Complementary and alternative medicine 54
- Toxicology 22
Countries citing papers authored by Fu‐Cai Ren
This map shows the geographic impact of Fu‐Cai Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu‐Cai Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu‐Cai Ren more than expected).
Fields of papers citing papers by Fu‐Cai Ren
This network shows the impact of papers produced by Fu‐Cai Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu‐Cai Ren. The network helps show where Fu‐Cai Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu‐Cai Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 126 | |
| 2 | 2008 | 47 | |
| 3 | 2009 | 45 | |
| 4 | 2010 | 36 | |
| 5 | 2012 | 30 | |
| 6 | 2018 | 29 | |
| 7 | 2013 | 22 | |
| 8 | 2018 | 20 | |
| 9 | 2011 | 19 | |
| 10 | 2016 | 18 | |
| 11 | 2020 | 17 | |
| 12 | 2018 | 16 | |
| 13 | 2017 | 14 | |
| 14 | 2013 | 14 | |
| 15 | 2023 | 13 | |
| 16 | 2022 | 13 | |
| 17 | 2015 | 13 | |
| 18 | 2017 | 13 | |
| 19 | 2013 | 12 | |
| 20 | 2018 | 12 |
About Fu‐Cai Ren
Fu‐Cai Ren is a scholar working on Molecular Biology, Plant Science, Pharmacology, Pharmacology and Organic Chemistry, having authored 50 papers that have together received 644 indexed citations. Recurring topics across this work include Phytochemistry and Biological Activities (17 papers), Natural product bioactivities and synthesis (17 papers), Bioactive natural compounds (10 papers), Traditional and Medicinal Uses of Annonaceae (7 papers), Sesquiterpenes and Asteraceae Studies (7 papers), Biological and pharmacological studies of plants (7 papers), Plant-based Medicinal Research (6 papers) and Bioactive Natural Diterpenoids Research (5 papers). The work is most often cited by research in Pharmacology (192 citations), Pharmacology (92 citations), Plant Science (275 citations), Complementary and alternative medicine (54 citations) and Toxicology (22 citations). Fu‐Cai Ren has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Ji‐Kai Liu, Fei Wang, Jiang‐Miao Hu, Yong-Feng Lv, Liu Yang, Jun Zhou, Jinyu Li, Guozhu Wei, Xiaobei Yang and Sha Yan. Their work appears in journals such as Molecules, Natural Products and Bioprospecting, Fitoterapia, Phytochemistry and Helvetica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.